文献速递产科母胎医学

妊娠期使用阿司匹林与出血并发症风险:一项瑞典基于人群的队列研究

Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2020-07-17

该研究基于瑞典妊娠登记处,纳入2013年1月至2017年7月分娩的313,624名妇女,采用倾向评分和逆概率治疗加权校正基线特征,评估妊娠期阿司匹林使用与产前、产时及产后出血风险的关联。结果显示阿司匹林使用与产时出血、产后出血、产后血肿及新生儿颅内出血风险升高相关,产前出血风险未见显著升高。

要点

  • 妊娠期阿司匹林使用与产时出血风险升高相关(调整OR 1.63,95%CI 1.30-2.05)。
  • 妊娠期阿司匹林使用与产后出血风险升高相关(调整OR 1.23,95%CI 1.08-1.39)。
  • 妊娠期阿司匹林使用与新生儿颅内出血风险升高相关(调整OR 9.66,95%CI 1.88-49.48)。

核心结论

  • 妊娠期使用阿司匹林与产后出血和产后血肿风险增加相关,也可能与新生儿颅内出血相关;提供阿司匹林时需权衡这些风险与潜在获益。

研究设计与样本

  • 基于瑞典妊娠登记处的登记库队列研究,纳入2013年1月至2017年7月分娩的313,624名妇女。
  • 采用逻辑回归评估产前、产时和产后出血风险,并使用倾向评分和逆概率治疗加权生成校正基线特征差异的比值比。

主要发现

  • 妊娠期阿司匹林使用登记于4088名(1.3%)妇女。
  • 与未使用阿司匹林者相比,阿司匹林使用与产前出血并发症无显著关联(调整OR 1.22,95%CI 0.97-1.54)。
  • 阿司匹林使用者产时出血发生率较高(2.9% vs 1.5%;调整OR 1.63,95%CI 1.30-2.05)。
  • 阿司匹林使用者产后出血发生率较高(10.2% vs 7.8%;调整OR 1.23,95%CI 1.08-1.39),产后血肿发生率较高(0.4% vs 0.1%;调整OR 2.21,95%CI 1.13-4.34)。
  • 新生儿颅内出血风险升高(0.07% vs 0.01%;调整OR 9.66,95%CI 1.88-49.48)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aspirin is offered to pregnant women to prevent preeclampsia, a severe obstetrical complication. Large studies of nonpregnant populations have consistently shown that aspirin prophylaxis increases the risk of hemorrhagic complications. However, there have not been any population-based studies investigating this in a pregnant population. OBJECTIVE: This study aimed to investigate whether aspirin use during pregnancy is associated with an increased risk of bleeding complications. STUDY DESIGN: We performed a register-based cohort study using the Swedish Pregnancy Register wherein we examined 313,624 women giving birth between January 2013 and July 2017. Logistic regression was used to assess the risk of antepartum, intrapartum, and postpartum hemorrhage. A propensity score and inverse probability treatment weighting was used to generate an odds ratio that corrects for differences in baseline characteristics. RESULTS: Aspirin use was registered in 4088 (1.3%) women during pregnancy. Compared with women who did not take aspirin, aspirin use was not associated with bleeding complications during the antepartum period (adjusted odds ratio, 1.22; 95% confidence interval, 0.97-1.54). However, aspirin users had a higher incidence of intrapartum bleeding (2.9% aspirin users vs 1.5% nonusers; adjusted odds ratio, 1.63; 95% confidence interval, 1.30-2.05), postpartum hemorrhage (10.2% vs 7.8%; adjusted odds ratio, 1.23; 95% confidence interval, 1.08-1.39), and postpartum hematoma (0.4% vs 0.1%; adjusted odds ratio, 2.21; 95% confidence interval, 1.13-4.34). The risk of a neonatal intracranial hemorrhage was also increased (0.07% vs 0.01%; adjusted odds ratio, 9.66; 95% confidence interval, 1.88-49.48). After stratifying by mode of birth, a higher incidence of bleeding among aspirin users was present for those who had a vaginal birth but not those who had a cesarean delivery. CONCLUSION: Using aspirin during pregnancy is associated with increased postpartum bleeding and postpartum hematoma. It may also be associated with neonatal intracranial hemorrhage. When offering aspirin during pregnancy, these risks need to be weighed against the potential benefits.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hastie R, Tong S, Wikström AK, et al. Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. Am J Obstet Gynecol. 2020. PMID: 32687818. doi:10.1016/j.ajog.2020.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。